Summary
Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH Microarrays, Next-Generation Sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic information to healthcare professionals, biopharma companies, and cancer centers. CGI’s clinical services include expand DX, test menu, complete program, and summation report. The company offers a range of pharmacogenomics testing services for clinical oncologists, cancer centers, and research institutions, and for biotech and biopharma customers engaged in clinical trials. It works in research collaboration with cancer centers to develop and validate proprietary tests. CGI is headquartered in Rutherford, New Jersey, the US.
Cancer Genetics Inc (CGIX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Cancer Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Cancer Genetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Cancer Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Cancer Genetics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Cancer Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Cancer Genetics Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Cancer Genetics Acquires Assets of Response Genetics for USD14 Million 11
Partnerships 12
Cancer Genetics Enters into Partnership with Mendel Health 12
Cancer Genetics Enters into Agreement with Lantern Pharma 13
Cancer Genetics Partners with ApoCell for ApoStream 14
Cancer Genetics Partners with H3 Biomedicine 14
Cancer Genetics Enters into Distribution Agreement with Sayre Therapeutics 15
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 16
Cancer Genetics Italia Enters Into Distribution Agreement With Nikon Instruments 16
Equity Offering 17
Cancer Genetics to Raise USD5.5 Million in Private Placement of Shares and Warrants 17
Cancer Genetics Raises USD5 Million in Private Placement of Shares and Warrants 18
Cancer Genetics Raises USD12 Million in Public Offering of Shares 20
Cancer Genetics Completes Public Offering Of Shares For US$46 Million 21
Cancer Genetic Announces Public Offering Of Common Stock For Up To US$50 Million 22
Cancer Genetics Completes Underwriters' Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For US$16 Million 23
Cancer Genetics Completes IPO For US$7 Million 25
Cancer Genetics Inc - Key Competitors 27
Key Employees 28
Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Strategy And Business Planning 31
Apr 03, 2017: Cancer Genetics and Mendel Announce Strategic Partnership Enabling Artificial Intelligence in Precision Medicine to Drive Personalized Treatment and Accelerate Clinical Trial Matching for Cancer Care 31
Feb 05, 2016: Cancer Genetics Expands the Reach of Precision Medicine by Over 2.6 Million Individuals as it Signs a New Agreement With Blue Cross Blue Shield of Minnesota 32
Financial Announcements 33
Mar 23, 2017: Cancer Genetics Announces Record Revenue for Fourth Quarter and Full-Year 2016 and Provides 2017 Business Update 33
Nov 10, 2016: Cancer Genetics Announces Strong Third Quarter with 68% Year over Year Revenue Growth and Highlights Path to Future Profitability 35
Aug 09, 2016: Cancer Genetics Reports Second Quarter 2016 Financial Results and Provides Company Updates 37
May 10, 2016: Cancer Genetics Announces 39% Revenue Increase and Provides Recent Company Highlights 39
Mar 10, 2016: Cancer Genetics Announces Strong Fourth Quarter and Full-Year 2015 Results and Provides 2016 Business Update 41
Corporate Communications 42
Jun 27, 2016: Cancer Genetics Names Healthcare Technology Industry Veteran John Jay Roberts as COO and Executive Vice President of Finance 42
Other Significant Developments 43
Jan 06, 2017: Cancer Genetics Announces Consolidation and Cost Reduction in Administrative and Operational Support Functions 43
Jun 02, 2016: Cancer Genetics Partners with ArcherDX to Offer Archer NGS Assays as a Sequencing Service for Biotech and Pharma 44
May 04, 2016: Cancer Genetics, Inc. Significantly Expands Marketshare In Immuno-Oncology Focused Clinical Trials With 12 Active Clinical Trials In Progress With Leading Biotech and Pharma Companies 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Tables
Cancer Genetics Inc, Medical Equipment, Key Facts, 2015 1
Cancer Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Cancer Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Cancer Genetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Cancer Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Cancer Genetics Inc, Deals By Market, 2011 to YTD 2017 9
Cancer Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Cancer Genetics Acquires Assets of Response Genetics for USD14 Million 11
Cancer Genetics Enters into Partnership with Mendel Health 12
Cancer Genetics Enters into Agreement with Lantern Pharma 13
Cancer Genetics Partners with ApoCell for ApoStream 14
Cancer Genetics Partners with H3 Biomedicine 14
Cancer Genetics Enters into Distribution Agreement with Sayre Therapeutics 15
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 16
Cancer Genetics Italia Enters Into Distribution Agreement With Nikon Instruments 16
Cancer Genetics to Raise USD5.5 Million in Private Placement of Shares and Warrants 17
Cancer Genetics Raises USD5 Million in Private Placement of Shares and Warrants 18
Cancer Genetics Raises USD12 Million in Public Offering of Shares 20
Cancer Genetics Completes Public Offering Of Shares For US$46 Million 21
Cancer Genetic Announces Public Offering Of Common Stock For Up To US$50 Million 22
Cancer Genetics Completes Underwriters' Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For US$16 Million 23
Cancer Genetics Completes IPO For US$7 Million 25
Cancer Genetics Inc, Key Competitors 27
Cancer Genetics Inc, Key Employees 28
Cancer Genetics Inc, Other Locations 30
Cancer Genetics Inc, Subsidiaries 30
List of Figures
Cancer Genetics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Cancer Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Cancer Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Cancer Genetics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Cancer Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Cancer Genetics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Cancer Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Cancer Genetics Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
